- An evaluation of treatments and survival rates for pancreatic adenocarcinoma through survival analysis with inverse probability of treatment weighting: a population-based studySuzhen, Wang; Chen, Wang; Fuyan, Shi; Enxue, Tao; Gaopei, Zhu; Juan, Li; Jianing, Feng; Xiaoxuan, Wang; Jing, Guo; Qingfeng, Zheng; Bo, ZhangJournal of Pancreatology, 2021, 4(1): 18-27.
- Treatment and outcomes of pancreatic cancer in Armenia: Hospital-based studyBardakhchyan, Samvel; Mkhitaryan, Sergo; Zohrabyan, Davit; Safaryan, Liana; Avagyan, Armen; Harutyunyan, Lilit; Arakelyan, Jemma; Gharadaghyan, Hovsep; Azizyan, Sahak; Mailyan, Mariam; Sargsyan, Amalya; Harutyunyan, Martin; Karapetyan, NuneAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- Subgroup Analysis by Ki-67 and Baseline CgA of the Randomized, Placebo-Controlled Phase 3 Study of Surufatinib in Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors (SANET-p)Yu, Xianjun; Xu, Jianming; Shen, Lin; Bai, Chunmei; Li, Jie; Zhou, Zhiwei; Li, Zhiping; Li, Enxiao; Yuan, Xianglin; Chi, Yihebali; Yin, Yongmei; Lou, Wenhui; Xu, Nong; Bai, Yuxian; Zhang, Tao; Xiu, Dianrong; Wang, Xiuwen; Guan, Sha; Fan, Songhua; Su, Weiguo
期刊论文
Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes
1被引15阅读
